State of Alaska, Department of Revenue

Position in ROIV — Roivant Sciences Ltd.

CIK 1370102 JUNEAU, AK

Position in ROIV

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$1,895,983

+$645,966 QoQ

Shares Held

53,574

+18.7% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#200

of 494 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

State of Alaska, Department of Revenue holds $93,905,322 across 47 Biotechnology names. ROIV ranks #15 (2.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	31,836	$15,813,895
2	HALO	Halozyme Therapeutics, Inc.	142,422	$11,147,368
3	REGN	Regeneron Pharmaceuticals, Inc.	17,215	$10,734,240
4	JAZZ	Jazz Pharmaceuticals plc	38,357	$9,242,885
5	KRYS	Krystal Biotech, Inc.	13,385	$4,974,801
6	CORT	Corcept Therapeutics Inc	40,107	$3,487,302
7	PTGX	Protagonist Therapeutics, Inc	28,084	$3,442,536
8	TGTX	Tg Therapeutics, Inc.	62,402	$3,428,365

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,895,983	53,574	+18.7%	Shares	Sole	2026-07-20
2026-03-31	$1,250,017	45,127	+4.1%	Shares	Sole	2026-04-20
2025-12-31	$940,738	43,352	-5.6%	Shares	Sole	2026-01-23
2025-09-30	$694,875	45,927	-2.9%	Shares	Sole	2025-10-24
2025-06-30	$532,958	47,290	-4.1%	Shares	Sole	2025-07-16
2025-03-31	$497,336	49,290	+0.7%	Shares	Sole	2025-04-21
2024-12-31	$579,255	48,965	-3.4%	Shares	Sole	2025-01-27
2024-09-30	$584,789	50,675	+37.0%	Shares	Sole	2024-10-24
2024-06-30	$391,090	37,000	0.0%	Shares	Sole	2024-08-05
2024-03-31	$389,980	37,000	—	Shares	Sole	2024-04-19
No filing history on record for this holder in this stock.